Table 1 Frequency of baseline variables the entire sample and comparison between patients with and without headache
Variable | All patients (n = 576) | Headache (n = 137) | No headache (n = 439) | Adjusted p-value |
|---|---|---|---|---|
Female sex | 250 (43.3%) | 80 (58.4%) | 170 (38.7%) | < 0.001 |
Age (years) | 67.2 (SD: 14.7) | 59.25 (SD: 12.4) | 69.6 (SD: 14.5) | < 0.001 |
Modified Rankin scale (mean) | 0.61 (SD: 1.12) | 0.15 (SD: 0.5) | 0.75 (SD: 1.2) | < 0.001 |
Hypertension | 300 (52.1%) | 52 (38%) | 248 (56.5%) | < 0.001 |
Diabetes | 113 (19.6%) | 20 (14.6%) | 93 (21.2%) | 0.090 |
Smoking | 118 (20.5%) | 20 (14.6%) | 98 (22.3%) | 0.050 |
Cardiological disorders | 154 (26.7%) | 19 (13.9%) | 135 (30.8%) | < 0.001 |
Pulmonary disorders | 145 (25.2%) | 33 (24.1%) | 112 (25.5%) | 0.737 |
Cancer | 94 (16.3%) | 18 (13.1%) | 76 (17.3%) | 0.249 |
Immuno-suppression | 24 (4.2%) | 4 (2.9%) | 20 (4.6%) | 0.409 |
Chronic neurological disorders | 105 (18.3%) | 13 (9.5%) | 92 (2%) | 0.002 |
Prior history of headache | 32 (5.6%) | 15 (10.9%) | 17 (3.9%) | 0.002 |
ACEis /ARBs | 215 (37.3%) | 42 (30.7%) | 173 (39.4%) | 0.064 |
NSAIDs | 75 (13%) | 12 (8.8%) | 66 (14.4%) | 0.090 |
Corticosteroids | 35 (6.1%) | 7 (5.1%) | 28 (6.4%) | 0.587 |
Neuropharmacological treatment | 203 (35.2%) | 42 (30.7%) | 161 (36.7%) | 0.198 |
Time symptoms-ED (days) | 7.34 (SD: 6.16) | 8.51 (SD: 5.90) | 6.98 (SD: 6.21) | 0.011 |